IQV
HEALTHCAREIQVIA Holdings Inc
$176.47+0.05 (+0.03%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving IQV Today?
No stock-specific AI insight has been generated for IQV yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$134.65$247.05
$176.47
Fundamentals
Market Cap$29.5B
P/E Ratio21.9
EPS$8.05
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume1.8M
Avg Volume (10D)—
Shares Outstanding166.9M
IQV News
32 articles- RSG Q1 Earnings Beat Estimates on Pricing & Margin GainsYahoo Finance·May 8, 2026
- Thermo Fisher’s New Cell Therapy Bioreactor And Bioprocess Hub Might Change The Case For Investing In TMOSimply Wall Street·May 8, 2026
- IQVIA Holdings Inc. (NYSE:IQV) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This YearSimply Wall Street·May 8, 2026
- Earnings Update: IQVIA Holdings Inc. (NYSE:IQV) Just Reported Its First-Quarter Results And Analysts Are Updating Their ForecastsYahoo Finance·May 8, 2026
- IQVIA Expands Share Repurchase Authorization by $2 BillionTipRanks·May 8, 2026
- IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase AuthorizationPharmiWeb.com·May 8, 2026
- IQVIA (NYSE: IQV) boosts buyback plan, $3.2B now authorizedStock Titan·May 7, 2026
- IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase AuthorizationBusiness Wire·May 7, 2026
- Corpay Set to Report Q1 Earnings: Here's What Investors Should KnowYahoo Finance·May 7, 2026
- IQVIA CFO to Speak at Bank of America Health Care Conference 2026BioSpace·May 7, 2026
- TRU Q1 Earnings Beat Estimates on Strong U.S. Financial ServicesYahoo Finance·May 6, 2026
- Here's What Key Metrics Tell Us About IQVIA (IQV) Q1 EarningsYahoo Finance·May 6, 2026
- IQV Q1 Earnings Beat on Commercial Solutions StrengthYahoo Finance·May 5, 2026
- IQVIA Holdings Inc. Q1 2026 Earnings Call SummaryMoby·May 5, 2026
- IQVIA (IQV) Q1 2026 Earnings Call TranscriptMotley Fool·May 5, 2026
- IQVIA Holdings (IQV) Q1 Earnings and Revenues Beat EstimatesYahoo Finance·May 5, 2026
- IQVIA’s (NYSE:IQV) Q1 CY2026 Sales Top EstimatesYahoo Finance·May 5, 2026
- IQVIA Reports First-Quarter 2026 ResultsYahoo Finance·May 5, 2026
- IQVIA Set to Report Q1 Earnings: Here's What You Should KnowYahoo Finance·May 4, 2026
- IQVIA (IQV) Reports Earnings Tomorrow: What To ExpectYahoo Finance·May 4, 2026
- A Look At IQVIA Holdings (IQV) Valuation After ESOP Linked Shelf Registration For Potential Share IssuanceYahoo Finance·Apr 29, 2026
- IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?Yahoo Finance·Apr 28, 2026
- 1 Healthcare Stock to Target This Week and 2 Facing HeadwindsYahoo Finance·Apr 27, 2026
- Why Eli Lilly Stock Flopped on FridayThe Motley Fool·Apr 24, 2026
- Can Eli Lilly’s Foundayo Catch Up to Novo’s Wegovy Pill?Yahoo Finance·Apr 24, 2026
- Clinical Trial Management System Research Report 2026: $4.2 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FGlobeNewswire Inc.·Apr 24, 2026
- Artificial Intelligence Clinical Trial Protocol Feasibility Tool Research Report 2026: $2.75+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035FGlobeNewswire Inc.·Apr 24, 2026
- Clinical Trial Data Visualization Research Report 2026: $1.82 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FGlobeNewswire Inc.·Apr 24, 2026
- AI-Based Clinical Trial Solution Providers Research Report 2026: $8.5+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FGlobeNewswire Inc.·Apr 24, 2026
- eCOA, eSource and Clinical Trials Research Report 2026: $81.46 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FGlobeNewswire Inc.·Apr 24, 2026
- 3 of Wall Street’s Favorite Stocks with Questionable FundamentalsYahoo Finance·Apr 22, 2026
- Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FGlobeNewswire Inc.·Apr 14, 2026
All 32 articles loaded
Price Data
Open$180.32
Previous Close$176.42
Day High$182.70
Day Low$175.77
52 Week High$247.05
52 Week Low$134.65
52-Week Range
$134.65$247.05
$176.47
Fundamentals
Market Cap$29.5B
P/E Ratio21.9
EPS$8.05
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume1.8M
Avg Volume (10D)—
Shares Outstanding166.9M
About IQVIA Holdings Inc
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—